Single intravenous injection of recombinant adeno-associated viral vector encoding a gain-of-function mutant PCSK9 (AAV-PCSK9) is a rapid and effective method to induce atherosclerosis in mice and a versatile tool for experimental atherosclerosis research (32). This evidence concerns the gene PCSK9 and atherosclerosis.